Sequenom, Inc., a leading provider of fine mapping genotyping, methylation and gene expression analysis solutions, announced the sales of multiple MassARRAY systems in China. Sequenom's new MassARRAY customers include the Beijing Genomics Institute (BGI), Asia's largest genetic sequencing centre, which plans to initially use the system for its advanced research in viral genetics and later for human genetic projects, and CapitalBio, a leading China-based life science service company with capacities for whole genome association studies, which plans to expand into the fine mapping market.

Dr. Wang Wei, BGI director of Viral Genotyping, said, "We chose Sequenom's MassARRAY technology because it features a unique combination of through-put, accuracy, sensitivity, reproducibility and cost efficiency. It is particularly suitable for the high-volume viral genotyping project and other population screening projects we plan to undertake in the near future."

Sequenom's President and CEO Harry Stylli, Ph.D. said, "We view the Chinese market as a very attractive opportunity to expand our genetic analysis business. We believe that sales to the distinguished research institute BGI and a leading service provider CapitalBio demonstrate the effectiveness of our activities to penetrate the growing Chinese market."

Established in 1999 and headquartered in Shenzhen, China, the Beijing Genomics Institute (BGI) is the largest genetic sequencing centre in Asia. BGI has been a core participant in all major international sequencing efforts, including the International Human Genome Project and the International HapMap Consortium.

CapitalBio is a leading life science company that develops and commercializes a broad range of products, including biochip technology products for drug discovery research, genomics, proteomics, bio-safety testing and clinical applications. Headquartered in Beijing, China, CapitalBio has rapidly evolved from a young innovative biochip developer into a comprehensive life science entity with five affiliates and subsidiaries:

Sequenom is committed to providing the best genomic and genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases.